Found: 26
Select item for more details and to access through your institution.
Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3679, doi. 10.1007/s00262-021-03024-0
- By:
- Publication type:
- Article
CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3701, doi. 10.1007/s00262-021-03008-0
- By:
- Publication type:
- Article
Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3397, doi. 10.1007/s00262-021-03004-4
- By:
- Publication type:
- Article
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3693, doi. 10.1007/s00262-021-02988-3
- By:
- Publication type:
- Article
Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3369, doi. 10.1007/s00262-021-02975-8
- By:
- Publication type:
- Article
Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3669, doi. 10.1007/s00262-021-02955-y
- By:
- Publication type:
- Article
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3643, doi. 10.1007/s00262-021-02951-2
- By:
- Publication type:
- Article
CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3603, doi. 10.1007/s00262-021-02949-w
- By:
- Publication type:
- Article
Human hydatid cyst fluid-induced therapeutic anti-cancer immune responses via NK1.1<sup>+</sup> cell activation in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3617, doi. 10.1007/s00262-021-02948-x
- By:
- Publication type:
- Article
IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3557, doi. 10.1007/s00262-021-02947-y
- By:
- Publication type:
- Article
Immune infiltrate diversity confers a good prognosis in follicular lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3573, doi. 10.1007/s00262-021-02945-0
- By:
- Publication type:
- Article
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3541, doi. 10.1007/s00262-021-02946-z
- By:
- Publication type:
- Article
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3651, doi. 10.1007/s00262-021-02944-1
- By:
- Publication type:
- Article
Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3477, doi. 10.1007/s00262-021-02937-0
- By:
- Publication type:
- Article
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3513, doi. 10.1007/s00262-021-02943-2
- By:
- Publication type:
- Article
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3421, doi. 10.1007/s00262-021-02940-5
- By:
- Publication type:
- Article
Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3461, doi. 10.1007/s00262-021-02939-y
- By:
- Publication type:
- Article
CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3501, doi. 10.1007/s00262-021-02941-4
- By:
- Publication type:
- Article
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3451, doi. 10.1007/s00262-021-02936-1
- By:
- Publication type:
- Article
Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3405, doi. 10.1007/s00262-021-02933-4
- By:
- Publication type:
- Article
The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3629, doi. 10.1007/s00262-021-02932-5
- By:
- Publication type:
- Article
Human leukocyte antigen I is significantly downregulated in patients with myxoid liposarcomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3489, doi. 10.1007/s00262-021-02928-1
- By:
- Publication type:
- Article
Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3435, doi. 10.1007/s00262-021-02927-2
- By:
- Publication type:
- Article
A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3587, doi. 10.1007/s00262-021-02923-6
- By:
- Publication type:
- Article
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3525, doi. 10.1007/s00262-021-02921-8
- By:
- Publication type:
- Article